menu
    • menu

    Company profile for Triastek

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Triastek, Inc. was founded in July 2015 by Dr. Senping Cheng, who has entrepreneurial experience in China and the United States, and Dr. Xiaoling Li, an American pharmaceutical expert and educator. Triastek is a dual-core-driven international pharmaceutical enterprise for 3D printing R&D and equipment development, and is committed to building a novel 3D printing pharmaceutical technology platform, forming a proprietary technol...
    Triastek, Inc. was founded in July 2015 by Dr. Senping Cheng, who has entrepreneurial experience in China and the United States, and Dr. Xiaoling Li, an American pharmaceutical expert and educator. Triastek is a dual-core-driven international pharmaceutical enterprise for 3D printing R&D and equipment development, and is committed to building a novel 3D printing pharmaceutical technology platform, forming a proprietary technology from dosage form design，product development method to intelligent manufacturing. Triastek’s mission is to become a global leader in the field of 3D printing pharmaceuticals.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TriastekChina Flag
    Country
    Country
    China
    Address
    Address
    12 East Mozhou Road, Future Sci-Tech City, P402 Nanjing, JiangSu
    Telephone
    Telephone
    86-25-52713121
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.triastek.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Triastek's 3D-Printed T20G Gets FDA IND Clearance
    Triastek's 3D-Printed T20G Gets FDA IND Clearance

    20 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250318799436/en/Triasteks-3D-Printed-Gastric-Retention-Product-T20G-Receives-FDA-IND-Clearance

    BUSINESSWIRE
    20 Mar 2025
    Share Share
    Triastek D23 Receives Positive Clinical Results
    Triastek D23 Receives Positive Clinical Results

    20 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250216386739/en

    BUSINESSWIRE
    20 Feb 2025
    Share Share
    Triastek's T22 Receives FDA Clearance of IND Application
    Triastek's T22 Receives FDA Clearance of IND Application

    31 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/01/31/2821071/0/en/Triastek-s-3D-Printed-Gastric-Retention-Product-T22-Receives-FDA-Clearance-of-IND-Application.html

    GLOBENEWSWIRE
    31 Jan 2024
    Share Share
    Triastek Completes USD 20.4 Million Pre-C Funding Round
    Triastek Completes USD 20.4 Million Pre-C Funding Round

    28 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/28/2751038/0/en/Triastek-Completes-USD-20-4-Million-Pre-C-Funding-Round-to-Accelerate-Commercialization-of-3D-Printing-Pharmaceutical-Technology-and-Products.html

    GLOBENEWSWIRE
    28 Sep 2023
    Share Share
    Triastek Reports Positive FIH Results from Study of T21
    Triastek Reports Positive FIH Results from Study of T21

    21 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/21/2708715/0/en/Triastek-Reports-Positive-FIH-Results-from-Study-of-T21-a-3D-Printed-Oral-Treatment-for-Moderate-to-Severe-Ulcerative-Colitis.html

    GLOBENEWSWIRE
    21 Jul 2023
    Share Share
    Triastek Reports Positive FIH Results from Study of T21
    Triastek Reports Positive FIH Results from Study of T21

    20 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/20/2708060/0/en/Triastek-Reports-Positive-FIH-Results-from-Study-of-T21-a-3D-Printed-Oral-Treatment-for-Moderate-to-Severe-Ulcerative-Colitis.html

    GLOBENEWSWIRE
    20 Jul 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search